Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0087 Transporter Info
Gene Name	SLC12A6
Transporter Name	Electroneutral potassium-chloride cotransporter 3
Gene ID	9990
UniProt ID	Q9UHW9

Post-Translational Modification of This DT
Overview of SLC12A6 Modification Sites with Functional and Structural Information
Sequence	M H P P E T T T K M A S V R F M V T P T K I D D I P G L S D T S P D L S S R S S S R V R F S S R E S V P E T S R S E P M S E M S G A T T S L A T V A L D P P S D R T S H P Q D V I E D L S Q N S I T G E H S Q L L D D G H K K A R N A Y L N N S N Y E E G D E Y F D K N L A L F E E E M D T R P K V S S L L N R M A N Y T N L T Q G A K E H E E A E N I T E G K K K P T K T P Q M G T F M G V Y L P C L Q N I F G V I L F L R L T W V V G T A G V L Q A F A I V L I C C C C T M L T A I S M S A I A T N G V V P A G G S Y F M I S R A L G P E F G G A V G L C F Y L G T T F A A A M Y I L G A I E I F L V Y I V P R A A I F H S D D A L K E S A A M L N N M R V Y G T A F L V L M V L V V F I G V R Y V N K F A S L F L A C V I V S I L A I Y A G A I K S S F A P P H F P V C M L G N R T L S S R H I D V C S K T K E I N N M T V P S K L W G F F C N S S Q F F N A T C D E Y F V H N N V T S I Q G I P G L A S G I I T E N L W S N Y L P K G E I I E K P S A K S S D V L G S L N H E Y V L V D I T T S F T L L V G I F F P S V T G I M A G S N R S G D L K D A Q K S I P I G T I L A I L T T S F V Y L S N V V L F G A C I E G V V L R D K F G D A V K G N L V V G T L S W P S P W V I V I G S F F S T C G A G L Q S L T G A P R L L Q A I A K D N I I P F L R V F G H S K A N G E P T W A L L L T A A I A E L G I L I A S L D L V A P I L S M F F L M C Y L F V N L A C A L Q T L L R T P N W R P R F R Y Y H W A L S F M G M S I C L A L M F I S S W Y Y A I V A M V I A G M I Y K Y I E Y Q G A E K E W G D G I R G L S L S A A R F A L L R L E E G P P H T K N W R P Q L L V L L K L D E D L H V K H P R L L T F A S Q L K A G K G L T I V G S V I V G N F L E N Y G E A L A A E Q T I K H L M E A E K V K G F C Q L V V A A K L R E G I S H L I Q S C G L G G M K H N T V V M G W P N G W R Q S E D A R A W K T F I G T V R V T T A A H L A L L V A K N I S F F P S N V E Q F S E G N I D V W W I V H D G G M L M L L P F L L K Q H K V W R K C S I R I F T V A Q L E D N S I Q M K K D L A T F L Y H L R I E A E V E V V E M H D S D I S A Y T Y E R T L M M E Q R S Q M L R H M R L S K T E R D R E A Q L V K D R N S M L R L T S I G S D E D E E T E T Y Q E K V H M T W T K D K Y M A S R G Q K A K S M E G F Q D L L N M R P D Q S N V R R M H T A V K L N E V I V N K S H E A K L V L L N M P G P P R N P E G D E N Y M E F L E V L T E G L E R V L L V R G G G S E V I T I Y S
PTM type	X-Acetylation X-N-glycosylation X-Oxidation X-Phosphorylation X-Ubiquitination X: Amino Acid

Acetylation
Lysine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A6			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	460
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC12A6 Lysine 460 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC12A6			[2]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	464
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC12A6 Lysine 464 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC12A6			[3]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	600
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC12A6 Lysine 600 has the potential to affect its expression or activity.
N-glycosylation
Asparagine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A6			[4]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	379
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC12A6 Asparagine 379 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC12A6			[4]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	398
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC12A6 Asparagine 398 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC12A6			[4]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	411
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC12A6 Asparagine 411 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC12A6			[4]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	428
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC12A6 Asparagine 428 has the potential to affect its expression or activity.
Oxidation
Cystine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A6			[5]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	827
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC12A6 Cystine 827 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC12A6			[5]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	846
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC12A6 Cystine 846 has the potential to affect its expression or activity.
Phosphorylation
Serine	30 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A6			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	12
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Serine 12 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC12A6			[8] , [9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	29
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Serine 29 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC12A6			[9] , [10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	32
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Serine 32 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC12A6			[8] , [11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	36
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Serine 36 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC12A6			[11] , [12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	37
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Serine 37 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC12A6			[13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	39
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Serine 39 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC12A6			[13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	40
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Serine 40 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC12A6			[13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	41
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Serine 41 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC12A6			[14] , [15]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	46
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Serine 46 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SLC12A6			[15] , [16]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	47
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Serine 47 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence SLC12A6			[14] , [15]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	50
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Serine 50 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence SLC12A6			[17] , [18]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	61
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Serine 61 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence SLC12A6			[17] , [18]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	64
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Serine 64 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence SLC12A6			[18] , [19]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	69
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Serine 69 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence SLC12A6			[18] , [20]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	79
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Serine 79 has the potential to affect its expression or activity.
PTM Phenomenon 16	Have the potential to influence SLC12A6			[14] , [21]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	93
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Serine 93 has the potential to affect its expression or activity.
PTM Phenomenon 17	Have the potential to influence SLC12A6			[11] , [13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	96
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Serine 96 has the potential to affect its expression or activity.
PTM Phenomenon 18	Have the potential to influence SLC12A6			[11] , [21]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	102
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Serine 102 has the potential to affect its expression or activity.
PTM Phenomenon 19	Have the potential to influence SLC12A6			[8] , [22]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	120
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Serine 120 has the potential to affect its expression or activity.
PTM Phenomenon 20	Have the potential to influence SLC12A6			[12] , [23]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	147
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Serine 147 has the potential to affect its expression or activity.
PTM Phenomenon 21	Have the potential to influence SLC12A6			[22] , [24]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	148
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Serine 148 has the potential to affect its expression or activity.
PTM Phenomenon 22	Have the potential to influence SLC12A6			[25]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	465
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Serine 465 has the potential to affect its expression or activity.
PTM Phenomenon 23	Have the potential to influence SLC12A6			[11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	734
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Serine 734 has the potential to affect its expression or activity.
PTM Phenomenon 24	Have the potential to influence SLC12A6			[11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	736
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Serine 736 has the potential to affect its expression or activity.
PTM Phenomenon 25	Have the potential to influence SLC12A6			[26]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	940
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Serine 940 has the potential to affect its expression or activity.
PTM Phenomenon 26	Have the potential to influence SLC12A6			[27]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	981
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Serine 981 has the potential to affect its expression or activity.
PTM Phenomenon 27	Have the potential to influence SLC12A6			[28] , [29]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1023
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Serine 1023 has the potential to affect its expression or activity.
PTM Phenomenon 28	Have the potential to influence SLC12A6			[8] , [30]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1029
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Serine 1029 has the potential to affect its expression or activity.
PTM Phenomenon 29	Have the potential to influence SLC12A6			[8] , [30]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1032
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Serine 1032 has the potential to affect its expression or activity.
PTM Phenomenon 30	Have the potential to influence SLC12A6			[9] , [11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1064
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Serine 1064 has the potential to affect its expression or activity.
Threonine	19 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A6			[31] , [32]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	18
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Threonine 18 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC12A6			[31] , [32]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	20
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Threonine 20 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC12A6			[9] , [33]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	31
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Threonine 31 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC12A6			[15] , [34]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	54
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Threonine 54 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC12A6			[18]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	67
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Threonine 67 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC12A6			[18]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	68
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Threonine 68 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC12A6			[18] , [19]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	72
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Threonine 72 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC12A6			[11] , [13]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	98
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Threonine 98 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC12A6			[35]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	157
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Threonine 157 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SLC12A6			[36]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	160
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Threonine 160 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence SLC12A6			[18]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	182
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Threonine 182 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence SLC12A6			[18]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	187
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Threonine 187 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence SLC12A6			[26]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	945
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Threonine 945 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence SLC12A6			[37] , [38]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	991
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Threonine 991 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence SLC12A6			[30] , [39]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1028
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Threonine 1028 has the potential to affect its expression or activity.
PTM Phenomenon 16	Have the potential to influence SLC12A6			[11] , [40]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1038
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Threonine 1038 has the potential to affect its expression or activity.
PTM Phenomenon 17	Have the potential to influence SLC12A6			[40] , [41]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1040
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Threonine 1040 has the potential to affect its expression or activity.
PTM Phenomenon 18	Have the potential to influence SLC12A6			[40] , [42]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1048
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Threonine 1048 has the potential to affect its expression or activity.
PTM Phenomenon 19	Have the potential to influence SLC12A6			[40] , [43]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1050
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Threonine 1050 has the potential to affect its expression or activity.
Tyrosine	7 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A6			[40] , [44]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	116
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Tyrosine 116 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC12A6			[12] , [40]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	122
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Tyrosine 122 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC12A6			[45] , [46]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	128
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Tyrosine 128 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC12A6			[47] , [48]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	156
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Tyrosine 156 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC12A6			[18]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	192
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Tyrosine 192 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC12A6			[49]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	965
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Tyrosine 965 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC12A6			[50]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	1121
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 Tyrosine 1121 has the potential to affect its expression or activity.
Unclear Residue	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Affecting the activity of the SLC12A6			[51]
Role of PTM	Protein Activity Modulation
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC12A6 have been reported to affect its transport activity.
Ubiquitination
Alanine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A6			[52]
Role of PTM	Potential impacts
Modified Residue	Alanine	Modified Location	591
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A6 Alanine 591 has the potential to affect its expression or activity.
Asparticacid	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A6			[52]
Role of PTM	Potential impacts
Modified Residue	Asparticacid	Modified Location	549
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A6 Asparticacid 549 has the potential to affect its expression or activity.
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A6			[52]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	541
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A6 Cystine 541 has the potential to affect its expression or activity.
Leucine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A6			[52]
Role of PTM	Potential impacts
Modified Residue	Leucine	Modified Location	585
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A6 Leucine 585 has the potential to affect its expression or activity.
Lysine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC12A6			[52] , [53]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	176
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A6 Lysine 176 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC12A6			[52] , [53]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	600
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A6 Lysine 600 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC12A6			[52] , [53]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	724
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC12A6 Lysine 724 has the potential to affect its expression or activity.

References
1	Re: The sinoatrial node, connexin distribution patterns and specific immunodetection of connexin45. Cardiovasc Res. 2002 Mar;53(4):1043-5; author reply 1046.
2	Mercurimetric determination of chloride in sweat. Clin Chim Acta. 2002 May 7;319(1):75-6.
3	Lysine succinylation is a frequently occurring modification in prokaryotes and eukaryotes and extensively overlaps with acetylation. Cell Rep. 2013 Aug 29;4(4):842-51.
4	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: S12A6_HUMAN)
5	A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
6	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
7	An Augmented Multiple-Protease-Based Human Phosphopeptide Atlas. Cell Rep. 2015 Jun 23;11(11):1834-43.
8	Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
9	Capillary Zone Electrophoresis-Tandem Mass Spectrometry for Large-Scale Phosphoproteomics with the Production of over 11,000 Phosphopeptides from the Colon Carcinoma HCT116 Cell Line. Anal Chem. 2019 Feb 5;91(3):2201-2208.
10	Global phosphoproteomic analysis reveals ARMC10 as an AMPK substrate that regulates mitochondrial dynamics. Nat Commun. 2019 Jan 10;10(1):104.
11	A Methodological Assessment and Characterization of Genetically-Driven Variation in Three Human Phosphoproteomes. Sci Rep. 2018 Aug 14;8(1):12106.
12	An integrated strategy for highly sensitive phosphoproteome analysis from low micrograms of protein samples. Analyst. 2018 Jul 23;143(15):3693-3701.
13	TiO2 with Tandem Fractionation (TAFT): An Approach for Rapid, Deep, Reproducible, and High-Throughput Phosphoproteome Analysis. J Proteome Res. 2018 Jan 5;17(1):710-721.
14	Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 Mar 28;8:14864.
15	Phosphoproteome Analysis Reveals Differential Mode of Action of Sorafenib in Wildtype and Mutated FLT3 Acute Myeloid Leukemia (AML) Cells. Mol Cell Proteomics. 2017 Jul;16(7):1365-1376.
16	Fast Global Phosphoproteome Profiling of Jurkat T Cells by HIFU-TiO2-SCX-LC-MS/MS. Anal Chem. 2017 Sep 5;89(17):8853-8862.
17	Kinase-substrate enrichment analysis provides insights into the heterogeneity of signaling pathway activation in leukemia cells. Sci Signal. 2013 Mar 26;6(268):rs6.
18	Characterization of native protein complexes and protein isoform variation using size-fractionation-based quantitative proteomics. Mol Cell Proteomics. 2013 Dec;12(12):3851-73.
19	In-Depth Analyses of B Cell Signaling Through Tandem Mass Spectrometry of Phosphopeptides Enriched by PolyMAC. Int J Mass Spectrom. 2015 Feb 1;377:744-753.
20	Identification of complex relationship between protein kinases and substrates during the cell cycle of HeLa cells by phosphoproteomic analysis. Proteomics. 2013 Apr;13(8):1233-46.
21	Integrative Phosphoproteomics Links IL-23R Signaling with Metabolic Adaptation in Lymphocytes. Sci Rep. 2016 Apr 15;6:24491.
22	UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515.
23	Defeating Major Contaminants in Fe3+- Immobilized Metal Ion Affinity Chromatography (IMAC) Phosphopeptide Enrichment. Mol Cell Proteomics. 2018 May;17(5):1028-1034.
24	Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function. Sci Signal. 2018 Aug 21;11(544):eaat6753.
25	Improve the coverage for the analysis of phosphoproteome of HeLa cells by a tandem digestion approach. J Proteome Res. 2012 May 4;11(5):2828-37.
26	Quantitative analysis of a phosphoproteome readily altered by the protein kinase CK2 inhibitor quinalizarin in HEK-293T cells. Biochim Biophys Acta. 2015 Jun;1854(6):609-23.
27	A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10762-7.
28	Phosphoproteome Profiling Reveals Molecular Mechanisms of Growth-Factor-Mediated Kinase Inhibitor Resistance in EGFR-Overexpressing Cancer Cells. J Proteome Res. 2016 Dec 2;15(12):4490-4504.
29	Time-resolved dissection of early phosphoproteome and ensuing proteome changes in response to TGF-beta. Sci Signal. 2014 Jul 22;7(335):rs5.
30	Phosphoproteomic and Functional Analyses Reveal Sperm-specific Protein Changes Downstream of Kappa Opioid Receptor in Human Spermatozoa. Mol Cell Proteomics. 2019 Mar 15;18(Suppl 1):S118-S131.
31	Phosphoproteomics to Characterize Host Response During Influenza A Virus Infection of Human Macrophages. Mol Cell Proteomics. 2016 Oct;15(10):3203-3219.
32	Phosphoproteomic Profiling Reveals Epstein-Barr Virus Protein Kinase Integration of DNA Damage Response and Mitotic Signaling. PLoS Pathog. 2015 Dec 29;11(12):e1005346.
33	Combined inhibition of receptor tyrosine and p21-activated kinases as a therapeutic strategy in childhood ALL. Blood Adv. 2018 Oct 9;2(19):2554-2567.
34	A fast sample processing strategy for large-scale profiling of human urine phosphoproteome by mass spectrometry. Talanta. 2018 Aug 1;185:166-173.
35	Targeted analysis of tyrosine phosphorylation by immuno-affinity enrichment of tyrosine phosphorylated peptides prior to mass spectrometric analysis. Methods. 2012 Feb;56(2):268-74.
36	Phosphoproteomic Analysis Reveals the Importance of Kinase Regulation During Orbivirus Infection. Mol Cell Proteomics. 2017 Nov;16(11):1990-2005.
37	p38-MK2 signaling axis regulates RNA metabolism after UV-light-induced DNA damage. Nat Commun. 2018 Mar 9;9(1):1017.
38	Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase. EMBO J. 2018 Dec 14;37(24):e99559.
39	Modulation of Cl- signaling and ion transport by recruitment of kinases and phosphatases mediated by the regulatory protein IRBIT. Sci Signal. 2018 Oct 30;11(554):eaat5018.
40	Comparative phosphoproteomic analysis reveals signaling networks regulating monopolar and bipolar cytokinesis. Sci Rep. 2018 Feb 2;8(1):2269.
41	Quantitative phosphoproteomic analysis reveals system-wide signaling pathways regulated by site-specific phosphorylation of Keratin-8 in skin squamous cell carcinoma derived cell line. Proteomics. 2017 Apr;17(7).
42	CEP128 Localizes to the Subdistal Appendages of the Mother Centriole and Regulates TGF-beta/BMP Signaling at the Primary Cilium. Cell Rep. 2018 Mar 6;22(10):2584-2592.
43	Tip-Based Fractionation of Batch-Enriched Phosphopeptides Facilitates Easy and Robust Phosphoproteome Analysis. J Proteome Res. 2018 Jan 5;17(1):46-54.
44	Toward a comprehensive characterization of a human cancer cell phosphoproteome. J Proteome Res. 2013 Jan 4;12(1):260-71.
45	Activating Mutations in PIK3CA Lead to Widespread Modulation of the Tyrosine Phosphoproteome. J Proteome Res. 2015 Sep 4;14(9):3882-3891.
46	Combination of chemical genetics and phosphoproteomics for kinase signaling analysis enables confident identification of cellular downstream targets. Mol Cell Proteomics. 2012 Apr;11(4):O111.012351.
47	Resolution of Novel Pancreatic Ductal Adenocarcinoma Subtypes by Global Phosphotyrosine Profiling. Mol Cell Proteomics. 2016 Aug;15(8):2671-85.
48	Finding the same needles in the haystack? A comparison of phosphotyrosine peptides enriched by immuno-affinity precipitation and metal-based affinity chromatography. J Proteomics. 2013 Oct 8;91:331-7.
49	Protein kinase PKN1 represses Wnt/beta-catenin signaling in human melanoma cells. J Biol Chem. 2013 Nov 29;288(48):34658-70.
50	Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
51	Phospho-regulation, nucleotide binding and ion access control in potassium-chloride cotransporters. EMBO J. 2021 Jul 15;40(14):e107294.
52	A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics. 2011 Oct;10(10):M111.013284.
53	Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence